ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1556

The Effect of Ginger Therapy On Symptoms of Osteoarthritis: An Open Pilot Study

Tessa Therkleson, Nursing, Edith Cowan University, Perth, Australia

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: alternative medicine, functional status, Health Assessment Questionnaire, osteoarthritis and pain

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Clinical Practice/Patient Care

Session Type: Abstract Submissions (ARHP)

Background/Purpose: Osteoarthritis (OA) is a painful, progressive disease of synovial joints characterised by deterioration of cartilage and bone and inflammation. Osteoarthritis of the knee and hip joints is common and a major cause of musculoskeletal pain and disability in older adults. In addition to conventional pharmacological management, people with OA often use complementary and alternative treatments. In vitro studies find ginger extract inhibits the inflammatory enzymes COX-2 and 5-lipoxygenase. Ginger seems to be absorbed after topical application by a compress that provides heat and relaxation therapy. European hospitals specialising in traditional therapies routinely use ginger compresses applied to the lower back for treatment of inflammatory conditions. In order for topical ginger treatments to be used more widely, a pre-packaged ginger patch was developed. This pilot study assessed the effects of the ginger compress and standardised ginger patch and the potential effect size of the treatments.

Methods: Twenty adult volunteers with osteoarthritis aged 35 – 90 years, recruited from medical centres and the community, were randomly assigned using a block size of 4, to ginger treatment with ginger compress (GC) or ginger patch (GP). Both treatments were provided daily for seven consecutive days at medical centres by trained nurses. While lying supine either a warm GC or GP was secured on the mid back for 45 minutes. All participants were offered a supply of the GP for self-treatment at home for the following 24 weeks. The 5-item modified Health Assessment Questionnaire (MHAQ) was used to assess pain, global effect, fatigue, functional status and health satisfaction. The MHAQ was completed once a week for 3 weeks and 4 weekly for 24 weeks. 

Results: Participants (mean age 64 years, 80% female) had a mean pain score at baseline of 2.1, with 3 being the most extreme pain. Most participants had OA of the hips and/or knees (17/20, 85%). All participants had a reduction in pain one week after ginger therapy, with a mean pain score 1.1. A comparison of MHAQ scores for the GC and GP groups show a strong co-relation, with p = 0.98 at baseline and p = 0.97 at 7 days. After seven days of ginger treatment the MHAQ mean total scores for all participants for pain, fatigue, global effect and functional status were reduced by 48%, 49%, 40% and 31% respectively, with scores progressively declining over the following 24 weeks. Pain, fatigue, global effect and functional status were all statistically significantly reduced from baseline to 7 days, 12 weeks and 24 weeks after therapy (p < 0.001). Health status satisfaction improved for both GC and GP, with 80% dissatisfied 7 days before therapy to 70% satisfied 7 days after therapy and 82% satisfied 24 weeks after therapy.

Conclusion: This pilot study suggests ginger therapy using both the ginger compress and ginger patch has the potential to relieve symptoms and increase independence for people with osteoarthritis. These data will be utilised in the design of a randomised placebo-controlled trial of the ginger patch.


Disclosure:

T. Therkleson,

RATO Health Ltd ,

4;

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-effect-of-ginger-therapy-on-symptoms-of-osteoarthritis-an-open-pilot-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology